Pycnogenol: 39 Trials In, and Blood Pressure Still Won't Make Up Its Mind

The Oasis Health Journal · Submitted July 5, 2026 · 5:20 PM ET

Pine trees shed bark. That is roughly the whole job description, along with photosynthesis and making people sneeze every April. But French maritime pine bark, the kind that grows along the coast of Les Landes in southwest France, has spent the last four decades getting turned into a patented extract called Pycnogenol, and getting run through more clinical trials than most prescription drugs bother with.

The scorecard so far: 39 randomized, double-blind, placebo-controlled human trials, more than 2,000 subjects, trial lengths from two weeks to six months, according to a 2024 review in Frontiers in Nutrition that gathered the whole body of research in one place. Pycnogenol is standardized to about 70 percent procyanidins, the same family of plant compounds that make red wine and dark chocolate feel vaguely medicinal. The rest is catechin, epicatechin, and taxifolin, which sound like spells and are actually just antioxidant polyphenols doing polyphenol things.

The Circulation Case

The strongest data lands on blood vessels. In a University of Zurich trial, 23 people with stable coronary artery disease took 200 mg of Pycnogenol or a placebo for eight weeks, then swapped. Flow-mediated dilation, a measure of how well an artery relaxes and widens under increased blood flow, improved from 5.3 to 7.0 percent with Pycnogenol, about a 32 percent jump from baseline and roughly 49 percent better than the placebo group, which barely moved. In a separate three-month trial of 58 people with hypertension, Pycnogenol lowered a vessel-tightening molecule called endothelin-1 by 16 percent versus placebo, and 57 percent of that group managed to cut their blood pressure medication in half, compared to 13 percent on placebo. That is the kind of result that gets a supplement invited to the cardiology conversation.

The Argument Nobody Has Settled

Here is the honest part. Several individual trials show Pycnogenol nudging blood pressure down. An eight-week crossover study of 11 people with borderline hypertension saw systolic pressure drop from 140 to 133 while the placebo group barely moved. A six-month trial of 155 perimenopausal women found both systolic and diastolic pressure falling further on Pycnogenol than on placebo, alongside better LDL and HDL numbers. Then a 2020 meta-analysis in the journal Angiology pooled seven of the cleaner randomized trials, 626 people total, and found no statistically significant effect on systolic pressure, diastolic pressure, or pulse pressure at all. An earlier, smaller pooled analysis had leaned the opposite way, toward a modest benefit. Two meta-analyses, same extract, opposite conclusions. This happens more often in nutrition science than anyone likes to admit, and it is exactly why one study, or one glowing label, should never be the whole argument.

Cholesterol and the Rest of the Résumé

The lipid data holds up better. That perimenopausal trial and a separate study in people with diabetes and hypertension both found LDL cholesterol dropping (9 to 12 percent) and HDL improving alongside Pycnogenol, on top of whatever medication people were already taking. Researchers also report benefits for joint comfort, skin elasticity, and reduced platelet clumping, the same anti-clotting mechanism worth flagging if you are already on blood thinners.

None of this makes Pycnogenol a replacement for medication or a fix for high blood pressure by itself. It makes it a genuinely well-studied plant extract with real cardiovascular signal and one unresolved argument about how much it actually moves the needle. We source ours fresh per order instead of letting it sit in a warehouse, which is slower than a two-day delivery habit and also the entire point, since potency fades with time on a shelf. Pair it with a steady CoQ10 or a daily omega-3 and you have a reasonably boring, evidence-informed cardiovascular stack, which is the best kind of stack to have.

The Fine Print

Studied doses run 100 to 200 mg a day, usually split into two doses since Pycnogenol clears the body fairly quickly. Side effects are mild and uncommon, mostly an upset stomach or mild dizziness. Because it can thin the blood slightly, talk to a doctor first if you take anticoagulants, run low blood pressure, or are prone to hypoglycemia. If you already lean on vitamin C for antioxidant support, Pycnogenol sits on that same shelf, next to the quercetin and flavonoid crowd, rather than replacing any of it.

Pine bark used to be something you stepped over on a hiking trail. Now it is capsules, a Zurich cardiology study, and an unresolved argument buried in the meta-analysis literature. Progress is strange like that.

This article is for educational purposes only and is not medical advice. Talk to your doctor before starting any new supplement, especially if you take blood pressure or blood-thinning medication.

Sources

1. Pycnogenol French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies, Frontiers in Nutrition (2024)
2. Effect of Pycnogenol on Blood Pressure: A PRISMA Compliant Systematic Review and Meta-Analysis, Angiology (2020)
3. Effect of pycnogenol supplementation on blood pressure: a systematic review and meta-analysis of clinical trials, Phytotherapy Research
4. Pycnogenol: benefits, dosage, and side effects, Examine.com
5. Pycnogenol: Skin, ADHD, Other Uses, Side Effects, Healthline